Gilead Sciences to acquire Immunomedics for $21 billion
Gilead Sciences Inc GILD.O will acquire biopharmaceutical company Immunomedics Inc IMMU.O for $21 billion.
News during the Pandemic
Gilead Sciences Inc GILD.O will acquire biopharmaceutical company Immunomedics Inc IMMU.O for $21 billion.
Unilever to spend 1 billion euros cutting fossil fuels from detergents.
A second wave of infections in Australia's coronavirus hot spot, the state of Victoria, eased further on Wednesday.
Medtronic said it would cut costs by $450 million to $475 million a year by fiscal 2023.
Japan's chief government spokesman, Yoshihide Suga, is set to announce on Wednesday his candidacy to lead the ruling Liberal Democratic…
The WGC-HSBC Champions has been cancelled because of government restrictions on international sporting events.
U.S. Secretary of State Mike Pompeo said on Tuesday he was hopeful that Chinese Confucius Institute cultural centers would all…
Lukashenko faces the biggest challenge of his 26-year rule since claiming victory in an election last month that opponents say…
Big Basin Redwoods State Park, California's oldest state park, has left it too dangerous for visitors.
A second wave of infections in Australia's coronavirus hot spot, the state of Victoria, eased further on Wednesday.